(EMAILWIRE.COM, February 02, 2019 ) The global radiotherapy market is projected to reach USD 6.8 billion by 2023 from USD 5.6 billion in 2018, at a CAGR of 4.1%. Growth in this market is largely driven by factors such as the growing global prevalence of cancer, increasing adoption of radiotherapy in clinical trials, and the increasing number of radiotherapy centers worldwide. However, the underdeveloped public health infrastructure in emerging countries
Download Free PDF Brochure Now at
http://www.reportsnreports.com/contacts/requestsample.aspx?name=172707
.
The major players in the market includeVarian Medical Systems, Inc. (US), Elekta AB (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc (US), P-cure Ltd. (Israel), Theragenics Corporation (US), and C.R.Bard, Inc. (US), among others.
Global radiotherapy market report analyzes by type, product type, application, end user, & region. Based on type, external beam radiotherapy segment accounted for largest share in 2016. Growing adoption of this therapy in emerging markets & development of advanced external beam radiotherapy devices to localize tumorous cells while minimizing harm to surrounding healthy cells are some of major factors contributing to growth of this market segment.
Radiotherapy market covers external beam radiotherapy & internal beam radiotherapy applications for various cancers. In 2016, prostate segment held largest share in both segments. Growing incidence of prostate cancer & high success rates achieved with external beam radiation are major factors driving growth of this market segment. This report studies radiotherapy market based on product type, type, application, & end user.
Complete report on Radiotherapy Market is Now Available at http://www.openpr.com/news/1512712/Top-Key-Players-in-Radiotherapy-Market-Shares-Size-Analysis-Forecast-Company-Profiles-Overview-Insights-Applications-Types-and-End-User-Forecast-to-2023.html .
This report focuses on various levels of analysisindustry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the radiotherapy market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
Competitive Landscape
1 Overview
2 Vendor Inclusion Criteria
3 Competitive Leadership Mapping
4 Visionary Leaders
5 Innovators
6 Dynamic Differentiators
7 Emerging Companies
8 Competitive Benchmarking
9 Analysis of Product Portfolio of Major Players in the Radiotherapy Market (25 Players)
10 Business Strategies Adopted By Major Players in the Radiotherapy Market (25 Players)
More Details on Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT), Internal (LDR, HDR) & Systemic), Product (Proton Beam, Cyberknife, LINAC, Seed, Samarium), Application (Prostate, Breast, Cervical), End User, and Region – Global Forecasts to 2022 report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=172707 .
Report covers radiotherapy market across four major geographies, namely, North America, Europe, Asia-Pacific, & Rest of the World (RoW). North America accounted for largest share of global radiotherapy market in 2016, followed by Europe. Large share of North American region mainly attributed to increasing healthcare expenditure in region, technological advancements, & high adoption of radiotherapy products owing to increasing incidence of cancer.
Breakdown of supply-side primary interviews:
By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (45%)
By Designation: C-level (26%), Director-level (30%), and Others (44%)
By Region: North America (35%), Europe (26%), APAC (23%), and RoW (16%)
Snehal
+ 18883915441
sales@reportsandreports.com
Source: EmailWire.Com 
